All Stories

  1. The Role of Host in the Spectrum of Outcomes in Family Clusters of Hepatitis Infection: From Asymptomatic to Hepatocellular Carcinoma

    Article • Case Reports in Gastroenterology, February 2023, Karger Publishers

    Hie-Won Hann

  2. Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: A Case Series

    Article • Current Cancer Therapy Reviews, September 2020, Bentham Science Publishers

    Hie-Won Hann

  3. An expert consensus for the management of chronic hepatitis B in Asian Americans

    Article • Alimentary Pharmacology & Therapeutics, February 2018, Wiley

    Hie-Won Hann

  4. HBV-related health behaviors in a socio-cultural context: Perspectives from Khmers and Koreans

    Article • Applied Nursing Research, May 2014, Elsevier

    Hie-Won Hann

  5. Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

    Article • Gastroenterology, April 2014, Elsevier

    Hie-Won Hann

  6. A long‐term study of the effects of antiviral therapy on survival of patients with HBV‐associated hepatocellular carcinoma (HCC) following local tumor ablation

    Article • Cancer Medicine, February 2014, Wiley

    Hie-Won Hann

  7. Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma

    Article • Journal of Vascular and Interventional Radiology, February 2013, Elsevier

    Hie-Won Hann

  8. Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients

    Article • PLoS ONE, October 2012, PLOS

    Hie-Won Hann

  9. Correlates of Hepatitis B Virus Health‐Related Behaviors of Korean Americans: A Situation‐Specific Nursing Theory

    Article • Journal of Nursing Scholarship, October 2012, Wiley

    Hie-Won Hann

  10. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection – Results from a clinic-based longitudinal cohort

    Article • European Journal of Cancer, October 2012, Elsevier

    Hie-Won Hann

  11. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection

    Article • European Journal of Cancer, May 2012, Elsevier

    Hie-Won Hann

  12. Telomere length in circulating serum DNA as a novel non‐invasive biomarker for cirrhosis: a nested case–control analysis

    Article • Liver International, April 2012, Wiley

    Hie-Won Hann

  13. Erratum to: Recognition and Management of HBV Infection in a Social Context

    Article • Journal of Cancer Education, December 2011, Springer Science + Business Media

    Hie-Won Hann

  14. The Management of Chronic Hepatitis B in Asian Americans

    Article • Digestive Diseases and Sciences, September 2011, Springer Science + Business Media

    Hie-Won Hann

  15. Recognition and Management of HBV Infection in a Social Context

    Article • Journal of Cancer Education, February 2011, Springer Science + Business Media

    Hie-Won Hann

  16. Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

    Article • Hepatology International, January 2011, Springer Science + Business Media

    Hie-Won Hann

  17. Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated

    Article • International Journal of Cancer, November 2010, Wiley

    Hie-Won Hann

  18. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses

    Article • Expert Opinion on Pharmacotherapy, August 2010, Informa Healthcare

    Hie-Won Hann

  19. Question of ALT flare during switch to adefovir from lamivudine: A single center open‐label, randomized, safety study (June 17, 2005 to February 5, 2009)

    Article • Journal of Medical Virology, July 2010, Wiley

    Hie-Won Hann

  20. W1817 Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment

    Article • Gastroenterology, May 2009, Elsevier

    Hie-Won Hann

  21. Hepatocellular Carcinoma Associated with Hepatitis B Virus

    Article • January 2009, Springer Science + Business Media

    Hie-Won Hann

  22. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B

    Article • Hepatology International, October 2008, Springer Science + Business Media

    Hie-Won Hann

  23. Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

    Article • Hepatology, September 2008, Wolters Kluwer Health

    Hie-Won Hann

  24. Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)

    Article • Hepatology International, February 2008, Springer Science + Business Media

    Hie-Won Hann

  25. Hepatocellular Carcinoma with Indeterminate or False-Negative Findings at Initial MR Imaging: Effect on Eligibility for Curative Treatment—Initial Observations 1

    Article • Radiology, September 2007, Radiological Society of North America (RSNA)

    Hie-Won Hann

  26. Proteomic Analysis of Serum Associated Fucosylated Glycoproteins in the Development of Primary Hepatocellular Carcinoma

    Article • Journal of Proteome Research, January 2006, American Chemical Society (ACS)

    Hie-Won Hann

  27. A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

    Article • Gastroenterology, August 2005, Elsevier

    Hie-Won Hann

  28. Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B

    Article • Journal of Gastroenterology and Hepatology, February 2005, Wiley

    Hie-Won Hann

  29. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

    Article • Gastroenterology, January 2004, Elsevier

    Hie-Won Hann

  30. SELDI-TOF-MS profiling of serum for detection of hepatocellular carcinoma progression in hepatitis B and hepatitis C infected patients

    Article • Gastroenterology, April 2003, Elsevier

    Hie-Won Hann

  31. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

    Article • Gastroenterology, September 2002, Elsevier

    Hie-Won Hann

  32. Hepatocellular Carcinoma After Systemic Chemotherapy: Gadolinium-Enhanced MR Measurement of Necrosis by Volume Histogram

    Article • Journal of Computer Assisted Tomography, July 2001, Wolters Kluwer Health

    Hie-Won Hann

  33. Serum Ferritin as a Predictor of Host Response to Hepatitis B Virus Infection

    Article • November 2000, World Scientific Pub Co Pte Lt

    Hie-Won Hann

  34. Depression in Korean Immigrants With Hepatitis B and Related Liver Diseases

    Article • Psychosomatics, November 2000, Elsevier

    Hie-Won Hann

  35. LAMIVUDINE TREATMENT OF HEPATITIS B FOLLOWING LIVER TRANSPLANTATION: A MULTI-CENTER U.S. STUDY.

    Article • Transplantation, April 2000, Wolters Kluwer Health

    Hie-Won Hann

  36. Lamivudine treatment for decompensated cirrhosis due to hepatitis B: A multicenter longitudinal study

    Article • Gastroenterology, April 2000, Elsevier

    Hie-Won Hann

  37. Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

    Article • New England Journal of Medicine, October 1999, New England Journal of Medicine (NEJM/MMS)

    Hie-Won Hann

  38. Hepatocellular Carcinoma: Association with Increased Iron Deposition in the Cirrhotic Liver at MR Imaging1

    Article • Radiology, July 1999, Radiological Society of North America (RSNA)

    Hie-Won Hann

  39. Cirrhosis: Multiobserver analysis of hepatic MR imaging findings in a heterogeneous population

    Article • Journal of Magnetic Resonance Imaging, March 1993, Wiley

    Hie-Won Hann

  40. MR imaging of hepatic iron overload in rat

    Article • Journal of Magnetic Resonance Imaging, January 1993, Wiley

    Hie-Won Hann

  41. Mass-like hepatic hypertrophy: MRI findings with histologic correlation

    Article • Magnetic Resonance Imaging, January 1992, Elsevier

    Hie-Won Hann

  42. Hepatocellular Tumors with High Signal on T1-Weighted MR Images

    Article • Journal of Computer Assisted Tomography, September 1991, Wolters Kluwer Health

    Hie-Won Hann

  43. Effect of iron and desferoxamine on cell growth andin vitro ferritin synthesis in human hepatoma cell lines

    Article • Hepatology, April 1990, Wolters Kluwer Health

    Hie-Won Hann

  44. Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinoma

    Article • International Journal of Cancer, March 1989, Wiley

    Hie-Won Hann

  45. Prevalence of hbeag and anti-hbe in chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma in korea

    Article • Hepatology, January 1985, Wolters Kluwer Health

    Hie-Won Hann

  46. IRON AND IRON BINDING PROTEINS IN PERSISTENT GENERALISED LYMPHADENOPATHY AND AIDS

    Article • The Lancet, February 1984, Elsevier

    Hie-Won Hann

  47. INHIBITORY EFFECTS OF ISOFERRITINS FROM TUMOUR AND NON-TUMOUR TISSUES ON E-ROSETTE FORMATION

    Article • The Lancet, January 1984, Elsevier

    Hie-Won Hann

  48. Hepatitis B virus and primary hepatocellular carcinoma: Family studies in Korea

    Article • International Journal of Cancer, July 1982, Wiley

    Hie-Won Hann

  49. Biologic Differences between Neuroblastoma Stages IV-S and IV

    Article • New England Journal of Medicine, August 1981, New England Journal of Medicine (NEJM/MMS)

    Hie-Won Hann

  50. Acute monoblastic leukemia in two infants: Clinical, histochemical, and immunologic investigations

    Article • Leukemia Research, January 1980, Elsevier

    Hie-Won Hann

  51. The periodic acid‐schiff reaction and prognosis in children with acute lymphoblastic leukemia

    Article • American Journal of Hematology, February 1979, Wiley

    Hie-Won Hann

  52. PRECIPITATING ANTIBODIES IN THE SERA OF TRANSFUSED PATIENTS: POSSIBLE CONFUSION WITH ANTI‐AU

    Article • International Journal of Immunogenetics, April 1974, Wiley

    Hie-Won Hann

  53. Post-Steroid Panniculitis in Acute Leukemia

    Article • New England Journal of Medicine, February 1971, New England Journal of Medicine (NEJM/MMS)

    Hie-Won Hann